← All grants

Investigator Initiated Multi-Site Clinical Trials (R01)

National Institutes of Health · Opportunity PAR-07-373

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities
• Native American tribal organizations (other)
• Nonprofits with 501(c)(3), other than higher education
• Nonprofits without 501(c)(3)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.

About this opportunity

-Purpose. The purpose of this Funding Opportunity Announcement is to provide a vehicle for submitting grant applications for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The trials may address any research question related to the mission and goals of NHLBI and may test clinical or behavioral interventions. Investigators should consult the NHLBI s Guidelines for Investigator Initiated Clinical Trials (http://www.nhlbi.nih.gov/funding/policies/clinical.htm) for more detailed instructions and information about multi-site clinical trial grant applications. Additional information about the mission, strategic plan and research interests of the NHLBI can be found at NHLBI s website (http://www.nhlbi.nih.gov/index.htm). -This Funding Opportunity Announcement is not intended for support of single-center studies or multi-center observational studies that are not testing an intervention. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Awards may be converted by NHLBI to cooperative agreements (U01).

Apply on grants.gov →

Similar grants still open